Detalhe da pesquisa
1.
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells.
Cell
; 186(21): 4567-4582.e20, 2023 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794590
2.
Adoptive immunotherapy for cancer or viruses.
Annu Rev Immunol
; 32: 189-225, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24423116
3.
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells.
Immunity
; 56(10): 2388-2407.e9, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776850
4.
FOXO1 is a master regulator of memory programming in CAR T cells.
Nature
; 629(8010): 211-218, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38600391
5.
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 602(7897): 503-509, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35110735
6.
Beyond youth: Understanding CAR T cell fitness in the context of immunological aging.
Semin Immunol
; 70: 101840, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37729825
7.
The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling.
Nat Immunol
; 14(6): 593-602, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23603793
8.
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.
Immunity
; 44(2): 380-90, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26885860
9.
Publisher Correction: FOXO1 is a master regulator of memory programming in CAR T cells.
Nature
; 629(8011): E11, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654101
10.
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells.
Nature
; 558(7709): 307-312, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29849141
11.
Two cases of severe pulmonary toxicity from highly active mesothelin-directed CAR T cells.
Mol Ther
; 31(8): 2309-2325, 2023 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312454
12.
Author Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 612(7941): E22, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477542
13.
Joint profiling of chromatin accessibility and CAR-T integration site analysis at population and single-cell levels.
Proc Natl Acad Sci U S A
; 117(10): 5442-5452, 2020 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32094195
14.
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing.
Mol Cancer
; 21(1): 78, 2022 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35303871
15.
Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals.
Mol Ther
; 29(2): 626-635, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33186691
16.
Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy.
Blood
; 134(1): 44-58, 2019 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076448
17.
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.
Immunity
; 44(3): 712, 2016 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843072
18.
An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer.
Am J Hematol
; 94(S1): S3-S9, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30680780
19.
Dominant-Negative TGF-ß Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication.
Mol Ther
; 26(7): 1855-1866, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29807781
20.
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia.
Blood
; 127(9): 1117-27, 2016 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26813675